• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于乙酰辅酶A的新分光光度法和放射化学分析法:适用于多种芳胺的芳胺N-乙酰转移酶。

New spectrophotometric and radiochemical assays for acetyl-CoA: arylamine N-acetyltransferase applicable to a variety of arylamines.

作者信息

Andres H H, Klem A J, Szabo S M, Weber W W

出版信息

Anal Biochem. 1985 Mar;145(2):367-75. doi: 10.1016/0003-2697(85)90376-8.

DOI:10.1016/0003-2697(85)90376-8
PMID:4014668
Abstract

Simple and sensitive spectrophotometric and radiochemical procedures are described for the assay of acetyl-CoA:arylamine N-acetyltransferase (NAT; EC 2.3.1.5), which catalyzes the reaction acetyl-CoA + arylamine----N-acetylated arylamine + CoASH. The methods are applicable to crude tissue homogenates and blood lysates. The spectrophotometric assay is characterized by two features: (i) NAT activity is measured by quantifying the disappearance of the arylamine substrate as reflected by decreasing Schiff's base formation with dimethylaminobenzaldehyde. (ii) During the enzymatic reaction, the inhibitory product CoASH is recycled by the system acetyl phosphate/phosphotransacetylase to the substrate acetyl-CoA. The radiochemical procedure depends on enzymatic synthesis of [3H]acetyl-CoA in the assay using [3H]acetate, ATP, CoASH, and acetyl-CoA synthetase. NAT activity is measured by quantifying N-[3H]acetylarylamine after separation from [3H]acetate by extraction. Product inhibition by CoASH is prevented in this system by the use of acetyl-CoA synthetase.

摘要

本文描述了用于测定乙酰辅酶A:芳胺N - 乙酰转移酶(NAT;EC 2.3.1.5)的简单且灵敏的分光光度法和放射化学法,该酶催化乙酰辅酶A + 芳胺→N - 乙酰化芳胺 + 辅酶A的反应。这些方法适用于粗制组织匀浆和血液裂解物。分光光度法具有两个特点:(i)通过用二甲基氨基苯甲醛定量席夫碱形成减少所反映的芳胺底物消失来测量NAT活性。(ii)在酶促反应过程中,抑制性产物辅酶A通过乙酰磷酸/磷酸转乙酰酶系统循环回底物乙酰辅酶A。放射化学法依赖于在测定中使用[³H]乙酸盐、ATP、辅酶A和乙酰辅酶A合成酶酶促合成[³H]乙酰辅酶A。通过萃取从[³H]乙酸盐中分离后,通过定量N - [³H]乙酰芳胺来测量NAT活性。在该系统中,通过使用乙酰辅酶A合成酶可防止辅酶A的产物抑制。

相似文献

1
New spectrophotometric and radiochemical assays for acetyl-CoA: arylamine N-acetyltransferase applicable to a variety of arylamines.用于乙酰辅酶A的新分光光度法和放射化学分析法:适用于多种芳胺的芳胺N-乙酰转移酶。
Anal Biochem. 1985 Mar;145(2):367-75. doi: 10.1016/0003-2697(85)90376-8.
2
Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol.人膀胱胞质溶胶中乙酰辅酶A依赖性芳胺N-乙酰基转移酶的多态性表达以及乙酰辅酶A依赖性O-乙酰基转移酶介导的N-羟基芳胺激活作用
Cancer Res. 1989 May 1;49(9):2448-54.
3
Assay for acetyl-CoA:arylamine N-acetyltransferase by high-performance liquid chromatography applied to serotonin N-acetylation.通过应用于血清素N-乙酰化的高效液相色谱法检测乙酰辅酶A:芳胺N-乙酰基转移酶
Biochim Biophys Acta. 1990 Jan 19;1037(1):1-6. doi: 10.1016/0167-4838(90)90094-v.
4
Characterization of the active site, substrate specificity and kinetic properties of acetyl-CoA:arylamine N-acetyltransferase from pigeon liver.鸽肝乙酰辅酶A:芳胺N - 乙酰基转移酶的活性位点、底物特异性及动力学特性的表征
Biochim Biophys Acta. 1983 Aug 16;746(3):193-201. doi: 10.1016/0167-4838(83)90074-2.
5
Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.C57BL/6J、A/J、AC57F1以及快速和慢速乙酰化的A.B6和B6.A同源近交系小鼠中乙酰辅酶A依赖性芳胺N-乙酰基转移酶、肼N-乙酰基转移酶和N-羟基芳胺O-乙酰基转移酶的遗传控制
Drug Metab Dispos. 1988 May-Jun;16(3):341-7.
6
On the active site of liver acetyl-CoA. Arylamine N-acetyltransferase from rapid acetylator rabbits (III/J).关于肝脏乙酰辅酶A的活性位点。来自快速乙酰化兔(III/J)的芳胺N-乙酰基转移酶。
J Biol Chem. 1988 Jun 5;263(16):7521-7.
7
A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N-acetyltransferase one (NAT1) and the first transacetylation step of catalysis.
Biochem Pharmacol. 1997 Jan 10;53(1):11-6. doi: 10.1016/s0006-2952(96)00592-8.
8
Purification and partial characterization of chicken liver acetyl coenzyme A: arylamine N-acetyltransferase.鸡肝乙酰辅酶A:芳胺N - 乙酰转移酶的纯化及部分特性鉴定
Comp Biochem Physiol B. 1987;86(3):601-6. doi: 10.1016/0305-0491(87)90455-x.
9
N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits.N-乙酰化药物遗传学:基因缺失导致慢乙酰化兔肝脏中芳胺N-乙酰转移酶缺乏。
Proc Natl Acad Sci U S A. 1989 Dec;86(23):9554-7. doi: 10.1073/pnas.86.23.9554.
10
Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.近交系仓鼠组织胞质溶胶中S-乙酰辅酶A依赖性酶对致癌性N-羟基芳胺的乙酰化基因型依赖性代谢激活:与芳胺N-乙酰基转移酶的关系。
Carcinogenesis. 1987 Dec;8(12):1767-74. doi: 10.1093/carcin/8.12.1767.

引用本文的文献

1
Treatment of Rats with Apocynin Has Considerable Inhibitory Effects on Arylamine N-Acetyltransferase Activity in the Liver.用夹竹桃麻素处理大鼠对肝脏中的芳胺N - 乙酰转移酶活性有显著的抑制作用。
Sci Rep. 2016 May 31;6:26906. doi: 10.1038/srep26906.
2
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.通过底物特异性和抑制剂结合确定的小鼠1型芳胺N - 乙酰基转移酶与人2型芳胺N - 乙酰基转移酶之间的差异。
BMC Pharmacol Toxicol. 2014 Nov 29;15:68. doi: 10.1186/2050-6511-15-68.
3
From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2.
从芳胺N-乙酰基转移酶到叶酸依赖性乙酰辅酶A水解酶:叶酸对(人类)NAT1及其同源物(小鼠)NAT2活性的影响。
PLoS One. 2014 May 13;9(5):e96370. doi: 10.1371/journal.pone.0096370. eCollection 2014.
4
Downregulation of hepatic acetylation of drugs in chronic renal failure.慢性肾衰竭时肝脏药物乙酰化作用下调。
J Am Soc Nephrol. 2008 Jul;19(7):1352-9. doi: 10.1681/ASN.2007090974. Epub 2008 Apr 16.
5
Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa.铜绿假单胞菌芳胺N-乙酰基转移酶的动力学特性分析
BMC Biochem. 2007 Mar 20;8:3. doi: 10.1186/1471-2091-8-3.
6
Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.乙酰化药物遗传学。慢乙酰化者表型是由人肝脏中芳胺N - 乙酰转移酶减少或缺乏所致。
J Clin Invest. 1990 Mar;85(3):968-72. doi: 10.1172/JCI114527.